Seroflo 250 Inhaler (Salmeterol 25 mcg + Fluticasone 250 mcg)

Description

What Is Seroflo 250 Inhaler?

Seroflo 250 Inhaler is a combination prescription respiratory medication manufactured by Cipla Ltd, one of India’s leading pharmaceutical companies. Each actuation (puff) of the inhaler delivers Salmeterol 25 mcg and Fluticasone Propionate 250 mcg — a carefully balanced pairing of a long-acting bronchodilator and an inhaled corticosteroid (ICS).

It is used for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and above. Seroflo 250 is a preventer inhaler, not a rescue inhaler — it must be used regularly every day, even when there are no symptoms, to control the underlying airway inflammation and prevent attacks from occurring.

Important: Seroflo 250 Inhaler must never be used to treat sudden breathing difficulty or an acute asthma attack. Always keep a separate short-acting reliever inhaler (such as salbutamol) available for emergency use.

Composition

The standard Seroflo 250 Inhaler is a metered-dose inhaler (MDI) containing 120 actuations. Cipla also manufactures the same combination in Rotacap and Multihaler formats. The 250 mcg fluticasone content places Seroflo 250 in the medium-to-high ICS dose range, suitable for patients with moderate-to-severe persistent asthma or COPD. Patients with milder disease may be better served by Seroflo 125 Inhaler (Salmeterol 25 mcg + Fluticasone 125 mcg), which delivers a lower steroid dose.

How Seroflo 250 Inhaler Works

Salmeterol: Long-Acting Bronchodilator

Salmeterol is a selective, long-acting beta-2 adrenoceptor agonist (LABA). Its unique molecular structure features a long lipophilic side chain that anchors it to the surface of the beta-2 receptor in airway smooth muscle, delivering sustained bronchodilation lasting approximately 12 hours from a single dose. When activated, beta-2 receptors relax smooth muscle throughout the bronchial tree, widen the airways, reduce airway resistance, and help prevent both exercise-induced and nocturnal bronchospasm.

Salmeterol must always be combined with an inhaled corticosteroid — it should never be used as the sole treatment in asthma.

Fluticasone Propionate: Inhaled Corticosteroid

Fluticasone propionate is a potent synthetic glucocorticoid with high affinity for the glucocorticoid receptor. Inhaled at recommended doses, it exerts powerful anti-inflammatory effects within the airways — reducing bronchial mucosal oedema, suppressing production of inflammatory mediators (leukotrienes, prostaglandins, cytokines), and dampening bronchial hyperresponsiveness to allergens, cold air, smoke, and exercise. Unlike oral steroids, inhaled fluticasone at standard doses acts primarily locally, with minimal systemic absorption and a much more favourable safety profile for long-term use.

Why ICS + LABA Combination Therapy Is Superior

The combination of fluticasone and salmeterol is synergistic: fluticasone upregulates beta-2 receptor expression, enhancing salmeterol’s bronchodilatory effect, while salmeterol’s receptor activation potentiates the anti-inflammatory action of fluticasone at the cellular level. Clinical trials consistently show that ICS + LABA combination inhalers provide superior asthma control, fewer exacerbations, and better lung function than equivalent doses of either component alone.

Uses of Seroflo 250 Inhaler

Asthma

Seroflo 250 is indicated in adults and adolescents (aged ≥12 years) whose asthma is not adequately controlled on an inhaled corticosteroid alone. Per GINA (Global Initiative for Asthma) 2024 guidelines, adding a LABA to an ICS is the recommended Step 3–4 strategy for patients with moderate-to-severe persistent asthma. Regular use of Seroflo 250 provides:

• Prevention of daytime and night-time wheeze, cough, and chest tightness
• Reduction in the frequency and severity of asthma attacks
• Measurable improvement in FEV1 and peak expiratory flow rate
• Reduced reliance on rescue bronchodilator inhalations
• Better overall symptom control and quality of life

Chronic Obstructive Pulmonary Disease (COPD)

Seroflo 250 is also indicated for maintenance treatment of COPD (including chronic bronchitis and emphysema) in adults with significant airflow limitation and a history of exacerbations. Current GOLD (Global Initiative for COPD) 2024 guidelines support ICS/LABA use in select COPD phenotypes — particularly patients with frequent exacerbations, elevated blood eosinophil counts, or features of asthma-COPD overlap. In COPD, Seroflo 250 reduces exacerbation frequency, improves exercise tolerance, and enhances quality of life.

Dosage and How to Use Seroflo 250 Inhaler

Recommended Dose

• Adults and adolescents (≥12 years), Asthma: 2 puffs twice daily — morning and evening, approximately 12 hours apart
• Adults, COPD: 2 puffs twice daily (morning and evening)

Each pair of puffs delivers 50 mcg salmeterol + 500 mcg fluticasone. Over a full day (4 puffs), the dose equates to 100 mcg salmeterol + 1,000 mcg fluticasone. Your doctor will titrate the dose based on disease severity, symptom control, and spirometry results.

Step-by-Step Inhaler Technique

1. Remove the mouthpiece cap and shake the inhaler vigorously for 5 seconds.
2. Breathe out fully and gently, away from the inhaler.
3. Hold the inhaler upright. Place the mouthpiece between your teeth and close your lips around it to form a good seal.
4. Begin breathing in slowly and steadily through your mouth.
5. Press the canister down firmly once while continuing to breathe in deeply.
6. Remove the inhaler from your mouth and hold your breath for 5–10 seconds, or as long as comfortable.
7. Breathe out slowly through your nose or pursed lips.
8. If a second puff is needed, wait 30 seconds, shake the inhaler, and repeat steps 2–7.
9. Always rinse your mouth with water and spit it out immediately after each use to remove deposited fluticasone and reduce the risk of oral thrush.
10. Replace the mouthpiece cap. Clean the mouthpiece weekly with a dry tissue.

Precautions and Warnings

• Not for acute attacks: Seroflo 250 acts too slowly to treat sudden breathlessness. Use a fast-acting reliever such as Asthalin HFA 100 mcg (Salbutamol) for emergencies. If you find yourself needing the reliever more than twice a week, contact your doctor — this is a sign of worsening control.
• Do not stop abruptly: Stopping fluticasone suddenly can cause rapid deterioration of symptoms. All dose reductions must be gradual and supervised.
• Oral thrush and hoarseness: Always rinse after use. If white patches develop in the mouth or throat, or severe hoarseness persists, consult your doctor — an antifungal treatment may be required.
• Systemic steroid effects with prolonged high-dose use: Adrenal suppression, cataracts, glaucoma, or reduced bone density may occur rarely. Your doctor will periodically review whether the dose can be stepped down.
• Pregnancy and breastfeeding: Well-controlled asthma is essential during pregnancy. Most experts consider ICS/LABA therapy at standard doses acceptable during pregnancy when required for disease control. Always discuss with your doctor.
• Children under 12: Seroflo 250 is not recommended. Lower-dose paediatric formulations are available.

Contraindications

• Known hypersensitivity to salmeterol, fluticasone propionate, or any inhaler excipient
• Use as rescue medication for acute asthma attacks or acute COPD exacerbations

Side Effects of Seroflo 250 Inhaler

Common Side Effects

• Oral thrush (oropharyngeal candidiasis) — prevented by rinsing the mouth after every use
• Hoarseness of voice (dysphonia)
• Throat irritation and cough
• Headache
• Tremor — fine hand tremor from salmeterol’s beta-2 stimulation; usually transient
• Palpitations or slightly increased heart rate
• Muscle cramps or joint pain

Less Common or Serious Side Effects

• Paradoxical bronchospasm — if breathing suddenly worsens immediately after inhalation, stop Seroflo immediately, use a reliever inhaler, and seek urgent medical advice
• Hypokalaemia (low blood potassium) — risk increases at high doses, especially with concurrent diuretics or theophylline
• Adrenal suppression — rare; associated with prolonged high-dose ICS use

Drug Interactions

• Beta-blockers (including ophthalmic drops): May antagonise salmeterol’s bronchodilating effect; generally avoided in asthma
• Strong CYP3A4 inhibitors (ketoconazole, ritonavir, cobicistat-containing antiretrovirals): Can substantially increase systemic fluticasone exposure, raising the risk of adrenal suppression and other corticosteroid effects; use with caution
• Other long-acting beta-agonists: Do not use another LABA alongside Seroflo 250
• Oral or injected corticosteroids: Adds to total systemic steroid burden; use the lowest effective dose of each
• Diuretics and xanthines: May compound the risk of hypokalaemia at high salmeterol doses

Related Respiratory Inhalers on IndoGenMed

IndoGenMed carries a comprehensive range of inhaled respiratory medicines for asthma and COPD:

• Seroflo 125 Inhaler (Salmeterol 25 mcg + Fluticasone 125 mcg) — a lower-dose ICS/LABA option for milder asthma
• Foracort 200 Rotacaps (Budesonide 200 mcg + Formoterol 6 mcg) — an alternative ICS/LABA combination, particularly useful in COPD
• Asthalin HFA 100 mcg Inhaler (Salbutamol) — the recommended short-acting reliever for acute attack relief
• Budecort 200 mcg Inhaler (Beclomethasone) — an inhaled corticosteroid monotherapy option
• Tiova 18 mcg Capsules (Tiotropium) — a once-daily LAMA for COPD maintenance

Storage

Store below 30°C, away from direct sunlight, heat, and frost. Do not pierce or incinerate the canister even when empty. Monitor the dose counter and replace the inhaler before it runs out. Keep out of reach of children. Do not use after the expiry date.

Frequently Asked Questions About Seroflo 250 Inhaler

Can I use Seroflo 250 when I am breathless during an attack?

No. Seroflo 250 is a daily maintenance inhaler — it does not act quickly enough to relieve acute breathlessness. For immediate relief, always use your fast-acting reliever inhaler (Asthalin HFA Salbutamol). If your reliever is not working or symptoms are severe, call emergency services immediately.

How long before Seroflo 250 starts to work?

Salmeterol provides bronchodilation within 10–20 minutes of the first dose. Fluticasone’s anti-inflammatory effect builds over days to weeks of regular use. Most patients notice meaningful improvement in symptom control within 1–2 weeks, with maximum benefit achieved after several weeks of consistent daily use.

Why must I rinse my mouth after using Seroflo 250?

Fluticasone deposited in the mouth and throat can encourage Candida yeast overgrowth, causing oral thrush — white patches on the tongue, inner cheeks, or throat. Rinsing with water immediately after every use and spitting it out removes residual medicine and greatly reduces this risk. A spacer device also helps reduce oropharyngeal deposition.

Can I stop Seroflo 250 if I feel fine?

No. Feeling well means the medicine is working. Stopping abruptly can cause rapid loss of asthma or COPD control and potentially trigger a severe attack. Always discuss any planned dose changes with your doctor, who will reduce treatment gradually when your condition is stably controlled.

Is Seroflo 250 safe for long-term daily use?

At prescribed doses, ICS/LABA combination inhalers are the cornerstone of long-term asthma and COPD management and are considered the safest available anti-inflammatory approach for airway disease. Regular medical reviews allow monitoring for any rare effects and ensure the lowest effective dose is used.

References

• Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2024. Available at: ginasthma.org
• Global Initiative for COPD (GOLD). GOLD 2024 Global Strategy Report. Available at: goldcopd.org
• NHS UK. Fluticasone Inhalers. Available at: nhs.uk
• MedlinePlus. Fluticasone and Salmeterol Oral Inhalation. Available at: medlineplus.gov